Immix Biopharma (IMMX) Tax Provisions (2021 - 2026)
Immix Biopharma (IMMX) reported Tax Provisions of $14,322 for Q2 2026, up 60.7% from $8,914 a year earlier.
Powered by 
Analysis
Immix Biopharma (IMMX) Tax Provisions (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immix Biopharma's Tax Provisions came in at $42,224, up 3.8% year-over-year; for FY2025, it came in at $37,724, down 8.1% from FY2024.
- Tax Provisions has a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- By year, Tax Provisions came in at $41,037 in FY2024 (+55.4%), $26,415 in FY2023 (+157.3%), $10,268 in FY2022 (+70.8%) and $6,013 in FY2021 (-65.7%).
- The Q2 2026 figure ranks as the highest quarterly Tax Provisions in data going back to Q1 2021.
- Year over year, Tax Provisions gained in five of the last seven quarters, with growth averaging 18.5%.
- The high point for year-over-year Tax Provisions in five years was Q3 2023 (growth of 307.1%); the low point was Q3 2025 (a decline of 30.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.15 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.21 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 662.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 654.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.01 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 291.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 393.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 242.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -407.00 Mn |
| 10 | Immix Biopharma | 541.74 Mn | 309.64 Mn | - | 14,322.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,322.00 |
| Dec 31, 2025 | 11,266.00 |
| Sep 30, 2025 | 7,722.00 |
| Jun 30, 2025 | 8,914.00 |
| Mar 31, 2025 | 9,822.00 |
| Dec 31, 2024 | 10,785.00 |
| Sep 30, 2024 | 11,144.00 |
| Jun 30, 2024 | 10,269.00 |
| Mar 31, 2024 | 8,839.00 |
| Dec 31, 2023 | 8,089.00 |
| Sep 30, 2023 | 6,807.00 |
| Jun 30, 2023 | 6,349.00 |
| Mar 31, 2023 | 5,170.00 |
| Dec 31, 2022 | 5,259.00 |
| Sep 30, 2022 | 1,672.00 |
| Jun 30, 2022 | 1,715.00 |
| Mar 31, 2022 | 1,622.00 |
| Dec 31, 2021 | 1,477.00 |
| Sep 30, 2021 | 1,337.00 |
| Jun 30, 2021 | 1,608.00 |
API Access
Immix Biopharma Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();